{"result": {"id": "33a28f9d-e440-454c-99b2-4aa486b05718", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"European Atherosclerosis Society Consensus Panel and Cardiovascular Research Community\",\n    \"summary\": \"This community is centered around the European Atherosclerosis Society Consensus Panel, a group of leading specialists in cardiovascular disease, and their collaborative research efforts with various authors and journals. The panel has published authoritative consensus statements in the European Heart Journal, focusing on the role of low-density lipoproteins (LDL) in atherosclerotic cardiovascular disease (ASCVD). The community includes researchers like Krauss RM, Ginsberg HN, Packard CJ, and Chapman MJ, who have contributed to these consensus statements. Additionally, the community encompasses research on combined hyperlipidemia and triglyceride-rich lipoproteins, published in journals such as the Journal of Clinical Lipidology and Current Atherosclerosis Reports. The relationships within this community highlight a collaborative network aimed at advancing understanding and management of cardiovascular diseases.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the community's significant contributions to cardiovascular disease research and its potential to influence clinical practices globally.\",\n    \"findings\": [\n        {\n            \"summary\": \"Central Role of the European Atherosclerosis Society Consensus Panel\",\n            \"explanation\": \"The European Atherosclerosis Society Consensus Panel stands as the central entity in this community, recognized for its authoritative consensus statements on atherosclerosis and related conditions. Its publications in the European Heart Journal, particularly the 2020 statement on LDL's role in ASCVD, underscore its influence in guiding evidence-based practices in cardiovascular health. The panel's work is pivotal in synthesizing current research to provide unified recommendations for healthcare professionals. [Data: Entities (3103), Relationships (4891, 4900, 4901, 4902, +more)]\"\n        },\n        {\n            \"summary\": \"Collaborative Research on Combined Hyperlipidemia\",\n            \"explanation\": \"Research on combined hyperlipidemia, a condition characterized by elevated cholesterol and triglycerides, represents a significant focus within this community. Authors like DRON JS, Gill PK, and Berberich AJ have contributed to studies published in the Journal of Clinical Lipidology, advancing the understanding of lipid disorders. Their collaborative efforts highlight the community's role in addressing complex metabolic disorders through research. [Data: Entities (4659, 4640, 4660), Relationships (4926, 4928, 4922, +more)]\"\n        },\n        {\n            \"summary\": \"Investigations into Triglyceride-Rich Lipoproteins\",\n            \"explanation\": \"The community includes research on triglyceride-rich lipoproteins and their association with ASCVD risk, as published in Current Atherosclerosis Reports. Authors such as Wadstr√∂m BN, Wulff AB, and Pedersen KM have contributed to this area, providing insights into lipid metabolism and cardiovascular risks. Their work exemplifies the community's commitment to exploring diverse aspects of cardiovascular disease. [Data: Entities (4635, 4649, 4650), Relationships (4907, 4908, 4909, +more)]\"\n        },\n        {\n            \"summary\": \"Studies on Dyslipidemia in Primary Care Settings\",\n            \"explanation\": \"Research on dyslipidemia in primary care settings, including studies published in BMJ Open and Vascular Health and Risk Management, reflects the community's interest in practical aspects of cardiovascular disease management. Authors like Asghari S, Laforest L, and their co-authors have explored single and mixed dyslipidemia in Canada and France, contributing valuable data for primary care practitioners. [Data: Entities (4638, 4639), Relationships (4916, 4919, 4920, 4921, +more)]\"\n        },\n        {\n            \"summary\": \"Global Impact of Cardiovascular Disease Research\",\n            \"explanation\": \"The community's research, including the global burden of cardiovascular diseases and risks study, underscores its worldwide impact. The reference to consensus statements from the European Atherosclerosis Society in such studies highlights the panel's influence on global cardiovascular health discussions. This global perspective is crucial for understanding the community's broader significance in addressing cardiovascular disease challenges. [Data: Entities (4628), Relationships (4891, +more)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752168793, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 868, "prompt_tokens": 3989, "total_tokens": 4857, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1920}, "prompt_cache_hit_tokens": 1920, "prompt_cache_miss_tokens": 2069}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            },\n            {\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }\n        ]\n    }\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nLimit the total report length to 2000 words.\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        },\n        {\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        },\n        {\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        },\n        {\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }\n    ]\n}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n4628,GLOBAL BURDEN OF CARDIOVASCULAR DISEASES AND RISKS,\"A study published in J Am Coll Cardiol on global cardiovascular disease burden\"\"\",1\r\n3103,EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL,\"The **European Atherosclerosis Society Consensus Panel** is an international expert panel composed of leading specialists in the field of cardiovascular disease. It is recognized for publishing authoritative consensus statements on atherosclerosis and related conditions, particularly atherosclerotic cardiovascular disease (ASCVD). In 2020, the panel released a significant consensus statement in the *European Heart Journal*, focusing on the role of low-density lipoproteins (LDL) in the development and management of ASCVD. This publication underscores the panel's commitment to advancing clinical understanding and guiding evidence-based practices in cardiovascular health.  \n\nAs a collaborative body of experts, the panel synthesizes current research and clinical insights to provide unified recommendations, aiding healthcare professionals in decision-making. Its work emphasizes the importance of LDL management in reducing cardiovascular risk, reflecting its broader mission to address key challenges in atherosclerosis. The European Atherosclerosis Society Consensus Panel serves as a vital resource for the medical community, ensuring that consensus-driven, up-to-date guidance is accessible to improve patient outcomes.\",11\r\n4633,KRAUSS RM,\"Krauss RM is one of the authors of the consensus statement from the European Atherosclerosis Society Consensus Panel published in the European Heart Journal in 2020.\"\"\",1\r\n4634,GINSBERG HN,\"Ginsberg HN is one of the authors of the consensus statement from the European Atherosclerosis Society published in the European Heart Journal in 2021.\"\"\",1\r\n4641,EUROPEAN HEART JOURNAL,\"The European Heart Journal published consensus statements from the European Atherosclerosis Society in 2020 and 2021.\"\"\",1\r\n4647,PACKARD CJ,\"Packard CJ is one of the authors of the consensus statement from the European Atherosclerosis Society published in 2021.\"\"\",1\r\n4648,CHAPMAN MJ,\"Chapman MJ is one of the authors of the consensus statement from the European Atherosclerosis Society published in 2021.\"\"\",1\r\n4659,DRON JS,\"**DRON JS** is a researcher who co-authored a study on combined hyperlipidemia, published in the *Journal of Clinical Lipidology* in 2021. The research contributes to the understanding of combined hyperlipidemia, a condition characterized by elevated levels of cholesterol and triglycerides in the blood. As one of the authors of this study, DRON JS has been involved in advancing knowledge in the field of lipidology, with findings that may inform clinical approaches to managing lipid disorders. The work underscores DRON JS's role in academic research and collaboration within the medical and scientific community.\",2\r\n4640,GILL PK,\"Gill PK is one of the authors of a study on combined hyperlipidemia and isolated hypertriglyceridemia published in the Journal of Clinical Lipidology in 2021.\"\"\",4\r\n4660,BERBERICH AJ,\"**BERBERICH AJ** is a researcher known for contributing to studies on combined hyperlipidemia. In 2021, Berberich co-authored a research paper on this topic, which was published in the *Journal of Clinical Lipidology*. The work focuses on the investigation and analysis of combined hyperlipidemia, a condition characterized by elevated levels of cholesterol and triglycerides in the blood. As a co-author, Berberich played a role in advancing the understanding of this metabolic disorder through collaborative research. The publication underscores Berberich's involvement in lipidology and contributions to the scientific community's knowledge of lipid metabolism and related cardiovascular risks.  \n\n(Word count: 99)\",2\r\n4635,WADSTR√ñM BN,\"Wadstr√∂m BN is one of the authors of a study on triglyceride-rich lipoproteins and low-density lipoproteins in the risk of ASCVD published in Current Atherosclerosis Reports in 2023.\"\"\",4\r\n4642,CURRENT ATHEROSCLEROSIS REPORTS,\"Current Atherosclerosis Reports published research on triglyceride-rich lipoproteins and low-density lipoproteins in 2023.\"\"\",1\r\n4649,WULFF AB,\"Wulff AB is one of the authors of research on triglyceride-rich lipoproteins published in Current Atherosclerosis Reports in 2023.\"\"\",1\r\n4650,PEDERSEN KM,\"Pedersen KM is one of the authors of research on triglyceride-rich lipoproteins published in Current Atherosclerosis Reports in 2023.\"\"\",1\r\n4638,ASGHARI S,\"Asghari S is one of the authors of a study on single and mixed dyslipidaemia in Canadian primary care settings published in BMJ Open in 2015.\"\"\",4\r\n4644,BMJ OPEN,\"BMJ Open published research on dyslipidaemia in Canadian primary care settings in 2015.\"\"\",1\r\n4655,AREF-ESHGHI E,\"Aref-Eshghi E is one of the authors of research on dyslipidaemia in Canada published in BMJ Open in 2015.\"\"\",1\r\n4656,GODWIN M,\"Godwin M is one of the authors of research on dyslipidaemia in Canada published in BMJ Open in 2015.\"\"\",1\r\n4639,LAFOREST L,\"Laforest L is one of the authors of a study on mixed dyslipidemias in primary care patients in France published in Vascular Health and Risk Management in 2012.\"\"\",4\r\n4645,VASCULAR HEALTH AND RISK MANAGEMENT,\"Vascular Health and Risk Management published a study on mixed dyslipidemias in France in 2012.\"\"\",1\r\n4657,AMBEGAONKAR BM,\"Ambegaonkar BM is one of the authors of research on mixed dyslipidemias in France published in Vascular Health and Risk Management in 2012.\"\"\",1\r\n4658,SOUCHET T,\"Souchet T is one of the authors of research on mixed dyslipidemias in France published in Vascular Health and Risk Management in 2012.\"\"\",1\r\n4646,JOURNAL OF CLINICAL LIPIDOLOGY,\"The Journal of Clinical Lipidology published research on combined hyperlipidemia in 2021.\"\"\",1\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\r\n4891,GLOBAL BURDEN OF CARDIOVASCULAR DISEASES AND RISKS,EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL,The study references consensus statements from the European Atherosclerosis Society,12\r\n4894,EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL,KRAUSS RM,Krauss RM is one of the authors of the consensus statement from the European Atherosclerosis Society Consensus Panel,12\r\n4895,EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL,GINSBERG HN,Ginsberg HN is one of the authors of the consensus statement from the European Atherosclerosis Society,12\r\n4900,EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL,EUROPEAN HEART JOURNAL,The Consensus Panel published their statements in the European Heart Journal,12\r\n4901,EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL,PACKARD CJ,Packard CJ is an author of the consensus statement from the European Atherosclerosis Society,12\r\n4902,EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL,CHAPMAN MJ,Chapman MJ is an author of the consensus statement from the European Atherosclerosis Society,12\r\n4926,DRON JS,GILL PK,Co-authors of a study on combined hyperlipidemia,6\r\n4928,BERBERICH AJ,GILL PK,Co-authors of a study on combined hyperlipidemia,6\r\n4907,WADSTR√ñM BN,CURRENT ATHEROSCLEROSIS REPORTS,Wadstr√∂m BN published research in Current Atherosclerosis Reports,5\r\n4908,WADSTR√ñM BN,WULFF AB,Wulff AB co-authored research with Wadstr√∂m BN,5\r\n4909,WADSTR√ñM BN,PEDERSEN KM,Pedersen KM co-authored research with Wadstr√∂m BN,5\r\n4916,ASGHARI S,BMJ OPEN,Asghari S published research in BMJ Open,5\r\n4917,ASGHARI S,AREF-ESHGHI E,Aref-Eshghi E co-authored research with Asghari S,5\r\n4918,ASGHARI S,GODWIN M,Godwin M co-authored research with Asghari S,5\r\n4919,LAFOREST L,VASCULAR HEALTH AND RISK MANAGEMENT,Laforest L published research in Vascular Health and Risk Management,5\r\n4920,LAFOREST L,AMBEGAONKAR BM,Ambegaonkar BM co-authored research with Laforest L,5\r\n4921,LAFOREST L,SOUCHET T,Souchet T co-authored research with Laforest L,5\r\n4922,GILL PK,JOURNAL OF CLINICAL LIPIDOLOGY,Gill PK published research in the Journal of Clinical Lipidology,5\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            },\n            {\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }\n        ]\n    }\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nLimit the total report length to 2000 words.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_1c794175da32ad727828d7cbdd51276cc032960d1831d4cee578b4ca7e5af081_v2"}